Instalab
logoInstalab

Nicotinamide

See whether your vitamin B3 supplement is actually raising the raw material your cells use for energy.
4.8 (4,161 reviews)
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home · 8-hour fast required
Get results
Explained with clear next steps, no medical jargon

Should you take a Nicotinamide test?

This test is most useful if any of these apply to you.

Taking a B3 or NAD Supplement
See whether your niacinamide, NR, or NMN is actually raising the building blocks in your blood, instead of guessing from how you feel.
Chasing Longevity and Aging Biology
Get an early, exploratory look at a molecule central to cellular energy and repair, and build your own baseline as the science matures.
Using High-Dose Niacinamide
If you take large daily doses for skin health, this shows how much is circulating and pairs well with liver monitoring.
Dialing In Your Supplement Dose
Response varies widely between people, so tracking your own before-and-after numbers helps you tailor a dose rather than copying someone else's.

About Nicotinamide

If you take a vitamin B3, NAD, or longevity supplement, this is one of the few blood tests that shows whether it is actually changing something measurable inside you. It answers a narrow question: how much of this specific building block is circulating in your blood right now?

This is a research-stage measurement, not an established diagnostic. There are no standardized healthy ranges, and a single reading carries far less weight than a trend you follow over time.

The Building Block Behind NAD+

Nicotinamide (a form of vitamin B3, also called niacinamide) is one of the raw materials your body uses to make NAD+ (a molecule every cell needs to turn food into energy and to repair damaged DNA). Your cells constantly break down and rebuild NAD+, and nicotinamide is a key recycled ingredient in that loop.

You also get it from food and from supplements. This test measures the concentration of free nicotinamide in your blood, not the NAD+ it eventually helps build, and not the other supplement forms like NR (nicotinamide riboside) or NMN (nicotinamide mononucleotide). Those are related molecules in the same pathway, but they are not the same measurement.

Why This Is a Research Marker, Not a Diagnostic

There is no agreed-upon threshold that separates a good level from a bad one, and the research linking a person's blood nicotinamide number to specific diseases is thin. Most of the strong human evidence is about nicotinamide taken as a supplement, not about what your measured level predicts.

That distinction matters. Nicotinamide the supplement has real human trial data in dermatology, where it has been studied for preventing common skin cancers in high-risk people, though results have been inconsistent across trials. But that evidence is about swallowing the vitamin, not about interpreting a blood concentration.

Raising the Number Does Not Prove a Benefit

One pattern runs through nearly all of this research: supplements reliably move the number, but moving the number does not reliably improve health. Human trials of NAD-boosting supplements consistently show the blood chemistry shifting as intended, while the outcomes people actually care about, like energy, metabolism, and aging markers, come back mixed or flat.

So a rising nicotinamide level confirms that a supplement is being absorbed and is present in your blood. It does not, by itself, mean your cells are healthier or aging more slowly. Treat this number as a measure of exposure, not proof of effect.

Why Two Labs Can Report Very Different Numbers

The biggest reason to be cautious with any single result is measurement variability. Reviews pooling many studies have found large differences in reported NAD-family concentrations depending on how the sample was handled and which laboratory technique was used, which makes results from different labs hard to compare directly.

  • Recent supplement dose: taking nicotinamide can raise your blood level more than a hundredfold within weeks, so a result reflects your recent intake far more than any stable baseline.
  • Sample handling and lab method: how blood is collected and processed, and the specific laboratory instrument used, can shift the reported number enough that two labs may disagree.
  • Rapid conversion: your body quickly turns excess nicotinamide into an inactive byproduct (called methyl-nicotinamide), so the level in your blood can change fast depending on how much is being used versus cleared.

Why One Reading Is Not Enough

Because a single value is so sensitive to timing, method, and recent intake, your own trend is far more informative than any one number. If you are starting or changing a supplement, a before-and-after comparison at the same lab tells you whether your level is actually moving.

A reasonable approach: get a baseline, retest in 8 to 12 weeks if you begin supplementing, then at least annually. Keep collection conditions consistent, ideally the same lab, the same time of day, and a consistent gap since your last dose, so you are comparing like with like.

One caveat rooted in the evidence: blood response to NAD-boosting supplements varies widely between people. Two people on the same dose can land in very different places, which is exactly why tracking your own numbers beats comparing to someone else's.

What to Do With an Unexpected Result

Because there are no validated cutpoints, no single value should trigger alarm or celebration. If a result surprises you, the first move is to repeat it under standardized conditions before drawing any conclusion.

For the fuller picture, this test is most useful alongside the rest of the NAD panel, since your active NAD+ and its related metabolites tell you more together than nicotinamide alone. If you take high doses (roughly above 3 grams per day), pair this with liver enzyme testing, because very high intake has been linked to reversible liver injury. People with kidney or liver disease clear nicotinamide more slowly and should involve a physician before supplementing at high doses.

What Moves This Biomarker

Evidence-backed interventions that affect your Nicotinamide level

Increase
Take oral nicotinamide (niacinamide) supplements
Taking nicotinamide directly and dramatically raises the amount circulating in your blood, which is exactly what this test captures. In a 48-week trial in adults with early Alzheimer's disease, 1,500 mg twice daily raised average blood nicotinamide more than 130-fold (to about 52 micromolar, a unit for very small blood concentrations). The catch: much of it was rapidly converted into an inactive byproduct (methyl-nicotinamide rose more than 600-fold), and raising the number has not been shown to reliably improve health outcomes, so a higher reading confirms absorption rather than benefit.
SupplementStrong Evidence
Increase
Take nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN), other forms of vitamin B3
These related supplements reliably raise whole-blood NAD+ (a related but different measurement from the nicotinamide this test captures). In healthy overweight adults, nicotinamide riboside raised whole-blood NAD+ by 22%, 51%, and 142% at 100, 300, and 1,000 mg over eight weeks. Whether they raise blood nicotinamide specifically was not directly measured, so treat this as pathway-level evidence rather than a proven effect on this exact number.
SupplementStrong Evidence

Frequently Asked Questions

Panels containing Nicotinamide

Nicotinamide is included in these pre-built panels.

References

18 studies
  1. Gabriel L Ketron, F. Grun, Joshua D. Grill, Howard H. Feldman, R. Rissman, G. BrewerAlzheimer's Research & Therapy2025
  2. Dassine Azouaoui, M. Choinière, Momtafin Khan, S. Sayfi, Simran Jaffer, Selvia Yousef, D. Patten, Alex E. Green, Keir J. MenziesScientific Reports2023
  3. A. H. Kuerec, Weilan Wang, Lin Yi, R. Tao, Zhigang Lin, Aditi Vaidya, Sohal Pendse, Sornaraja Thasma, Niranjan Andhalkar, Ganesh Avhad, Vidyadhar Kumbhar, a. B. MaierMechanisms of Ageing and Development2024
  4. Joshua D. Grill, S. Tam, G. Thai, B. Vides, Aimee L Pierce, Kim N Green, D. Gillen, Edmond Teng, Sarah Kremen, Maryam Beigi, R. Rissman, G. C. Léger, Archana Balasubramanian, C. Revta, Rosemary H. Morrison, R. Jennings, Judy Pa, Jing Zhang, Shelia Jin, Karen Messer, H. FeldmanNeurology2025